Dallas, TX 1/12/2010 1:37:26 AM
News / Business

ECOB, FDEI, PEIX, MDCE, EPCT and PLBI are the Jan. 11th Daily Market Movers Digest Picks from OTCPicks.com

Dallas- OTCPicks.com’s Daily OTC Stocks Newsletter presents a range of the hottest small cap, micro cap and penny stocks trading on the OTC and OTCBB markets. In addition to our Newsletters, OTCPicks.com is quickly becoming the premier community destination for small cap and micro cap traders to meet up and discuss their top stock picks.

Visit http://www.otcpicks.com/hotpicks.htm today to sign up for our Free Daily Email Newsletter and News Alerts.

Sign up for our Free Red Hot Stock Picks List at http://www.otcpicks.com/hotpicks.htm

Join us on Twitter at www.twitter.com/otcpicks

Join us on Facebook at www.facebook.com/otcpicks

ECOBLU PRODUCTS INCORPORATED (OTCBB: ECOB)

"Up 7.69% in morning trading"

Company Profile: http://www.otcpicks.com/ecoblu-products.htm

Biomagnetics Diagnostics Corporation is an advanced medical device and biotechnology company. The Company's revolutionary diagnostic systems, which are based on advanced magnetics, test for any viral or bacterial disease using any body fluid. The Company's technology allows laboratories to perform far more tests in the same amount of time it takes to do a single test. The HTS-MTP platform is designed to detect the actual virus and viral load in body fluids and not just simply screen for the presence of viral antibodies.

FIDELIS ENERGY INCORPORATED (OTC: FDEI)

"Up 300.00% in morning trading"

Fidelis Energy Inc. ("FDEI") is an energy company focused on developing, constructing and operating solar energy projects exclusively or in partnership with other energy companies. Fidelis is also in the development stage of designing solar photovoltaic (PV) cell technology products and plans to manufacture and distribute these products in the future. Fidelis owns a unique patent pending solar cell technology based on photovoltaic cells with integral light-transmitting wave guides in a ceramic sleeve. The advantage of this technology is the efficiency of less exposed surface area being required to generate electricity. The light-transmitting particles act as wave guides and allow the sun-exposed conversion area of the solar cell to be shifted readily from horizontal to vertical to capture more sunlight. The ceramic sleeve eliminates the need for expensive vacuum chambers, thereby allowing less expensive materials to be used in solar cell production. We are developing, with plans to eventually manufacture and market, innovative solar cells and solar power products for a wide range of applications based on our technology that increases light-trapping while enabling a variety of materials to be used. Our technology employs multiple stacked solar cells in a ceramic sleeve that uses nano-particles and crystal wave guides to carry light from the opening down to the last junction in the solar cell. Competitors' processes that use vacuum chambers (instead of a ceramic sleeve) generally don't allow for material substitution because of contamination issues. We believe our technology will also allow manufacturers to quickly and economically shift to new materials if a shortage of any one type of material occurs. In general, our technology will offer a flexible, cost-effective solution for increased light-trapping and will provide increased efficiency.

PACIFIC ETHANOL INCORPORATED (NASDAQ: PEIX)

"Up 49.47% in morning trading"

Pacific Ethanol is the largest West Coast-based marketer and producer of ethanol. Pacific Ethanol has ethanol plants in Madera, California; Boardman, Oregon; and Burley, Idaho and has an additional plant under construction in Stockton, California. Pacific Ethanol also owns a 42% interest in Front Range Energy, LLC which owns an ethanol plant in Windsor, Colorado. Central to Pacific Ethanol's growth strategy is its destination business model, whereby each respective ethanol plant achieves lower process and transportation costs by servicing local markets for both fuel and feed. Pacific Ethanol's goal is to achieve 220 million gallons per year of ethanol production capacity in 2008 and to increase total production capacity to 420 million gallons per year in 2010. In addition, Pacific Ethanol is working to identify and develop other renewable fuel technologies, such as cellulose-based ethanol production and bio-diesel.

MEDICAL CARE TECHNOLOGIES INCORPORATED (OTCBB: MDCE)

"Up 28.00% in morning trading"

Medical Care Technologies Inc. is traded under the symbol "MDCE" on the OTCBB and is based in London, England. The Company is in the process of moving its portfolio of oil resources into medical care technologies. The products/services that the company hopes to acquire are intended and will constitute a healthcare delivery and wellness site; dedicated to helping Asian consumers live healthier, more balanced lives. MDCE is planning to provide advanced connectivity, internationally standardized and secure business, technology and information systems to assist the Asian health industry — physicians, pharmacists, medical institutions, consumers — access medical resources, health services, education, wellness and pharmaceutical products throughout Asia. MDCE is planning to distribute and provide services at a diverse range of industry-leading product lines in three segments: Medical Devices, Pharmaceuticals and Nutraceuticals.

EPICEPT CORPORATION (NASDAQ: EPCT)

"Up 33.28% in morning trading"

EpiCept Corporation, a specialty pharmaceutical company, focuses on the development of pharmaceutical products for the treatment of cancer and pain. The company's lead oncology product candidate is Ceplene, which is used for the treatment of acute myeloid leukemia. Its cancer product portfolio includes Azixa, a Phase II clinical trial product to treat the patients with primary glioblastoma and melanoma that has metastasized to the brain and non-small-cell lung cancer that has spread to the brain; and EPC2407, a Phase I clinical trial completed oncology product candidate for the treatment of patients with advanced solid tumors and lymphomas. The company's pain product portfolio comprises EpiCept NP-1, a prescription topical analgesic cream for the long-term relief of peripheral neuropathies; LidoPAIN BP, a prescription analgesic non-sterile patch to provide sustained topical delivery of lidocaine for the treatment of acute or recurrent lower back pain; and LidoPAIN SP, a sterile prescription analgesic patch designed to provide sustained topical delivery of lidocaine to a post-surgical or post-traumatic sutured wound. It has strategic alliances with Endo Pharmaceuticals, Inc.; Myriad Genetics, Inc.; DURECT Corporation; Adolor Corporation; Epitome Pharmaceuticals Limited; and Shire Biochem, Inc. The company was founded in 1993 and is based in Tarrytown, New York.

PROTON LABORATORIES INCORPORATED (OTC: PLBI)

"Up 100.00% in morning trading"

Proton Laboratories, Inc. engages in design, manufacture, marketing, and sale of functional water systems in the United States. The company's functional water systems restructure tap water into one type of water that is alkaline in concentration and one type of water that is acidic in concentration. The company also formulates intellectual properties under licensing agreements; supplies consumer products; consults on projects utilizing functional water; and acts as educators on the benefits of functional electrolyzed water. For the residential market, the company markets functional water systems that are used to produce a health-beneficial, alkaline-concentrated drinking water. For the commercial market, the company markets commercial-grade functional water systems that are used in applications ranging from food preparation to hospital disinfection. Markets The company's products are used in various industries, including corporate agriculture, organic agriculture, food processing, medicine and dentistry, dermatology, heavy industry, mining, environmental clean-up, product formulations, and beverages. Competition The company’s major competitor is Hoshizaki U.S.A. Its potential competitors include Sterilox and Johnson and Johnson. History Proton Laboratories, Inc. was founded in 2000.

About OTCPicks.com

OTCPicks.com is an Internet destination for investors seeking information on smallcap and microcap and penny stocks. The web site features growing micro cap and penny stock companies. We publish a daily Free email newsletter highlighting the most active Pinksheets, OTCBB and penny stocks. To feature a company on our web site please contact our publisher, Brian Dean at 972-546-3740, or via email at publisher@otcpicks.com.

Forward-Looking Statement: This press release includes "forward-looking statements" within the meaning of the federal securities laws, commonly identified by such terms as "believes," "looking ahead," "anticipates," "estimates" and other terms with similar meaning. Although the Company believes that the assumptions upon which its forward-looking statements are based are reasonable, it can give no assurance that these assumptions will prove to be correct. Important factors that could cause actual results to differ materially from the Company's projections and expectations are disclosed in the Company's filings with the Securities and Exchange Commission. All forward-looking statements in this press release are expressly qualified by such cautionary statements and by reference to the underlying assumptions.

Disclosure: OTCPicks has been compensated five thousand dollars from a third party for ECOB advertising and promotional services.

OTCPicks.com is not a registered investment advisers or broker/dealer. OTCPicks.com makes no recommendation that the purchase of securities of companies profiled in this website is suitable or advisable for any person or that an investment such securities will be profitable. In general, given the nature of the companies profiled and the lack of an active trading market their securities, investing in such securities is highly speculative and carries a high degree of risk.